Ferredoxin reductase (FDXR), also known as nicotinamide adenine dinucleotide phosphate (NADPH): adrenodoxin oxidoreductase, mitochondrial is mapped to human chromosome 17q25.1. It is expressed in two isoforms and is encoded by 12 exons. It is a flavoprotein consisting of flavin adenine dinucleotide (FAD) and nicotinamide adenine dinucleotide (NAD) domains.
Synonyms: Anti-ADXR
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: Ferredoxin reductase (FXDR) functions as a shuttle protein and mediates electron transfer in the cytochrome P450 systems in mitochondria. FXDR is critical for the formation of iron-sulfur clusters. Mutations in FDXR gene is associated with mitochondrial disorders and may impact the function of optic and auditory neurons.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC